Literature DB >> 12390508

Decreased nocturnal melatonin levels during acute myocardial infarction.

Alberto Domínguez-Rodríguez1, Pedro Abreu-González, Martín J García, Juan Sanchez, Francisco Marrero, Diego de Armas-Trujillo.   

Abstract

Acute myocardial infarction is accompanied by an increase in cellular oxidative stress in the pericardial coverings of the heart. Melatonin is a highly potent and efficient radical scavenger. Little research has been carried out concerning the relationship between this antioxidant and acute myocardial infarction in humans. In this work, serum levels of melatonin and parameters of oxidative stress, such as glutathione peroxidase and lipid peroxidation levels were examined in light/dark periods in patients with acute myocardial infarction. Twenty-five patients diagnosed with acute myocardial infarction were studied and 25 patients with no evidence of coronary artery disease served as controls. Venous blood samples were obtained from the patients and control subjects to determine melatonin, glutathione peroxidase and lipid peroxidation; the samples were collected at 10:00 hr (light period) and 03:00 hr (dark period) in the first 24 hr after admission to the coronary care unit. Our results demonstrate the existence of differences between changes in melatonin levels in control subjects and acute myocardial infarction patients, revealing a reduced nocturnal elevation in the acute myocardial infarction group. Glutathione peroxidase levels were lower after acute myocardial infarction and did not show diurnal variations. In the control group, lipid peroxidation levels presented a light/dark pattern but in the acute myocardial infarction group diurnal variations of this parameter were lost. Our data show that acute myocardial infarction is associated with a nocturnal serum melatonin deficit as well as increased oxidative stress, suggesting that melatonin is, at least in part, depleted during the dark phase to reduce the free radicals formed in acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390508     DOI: 10.1034/j.1600-079x.2002.02938.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  19 in total

1.  The effect of solar-geomagnetic activity during and after admission on survival in patients with acute coronary syndromes.

Authors:  Jone Vencloviene; Ruta Babarskiene; Irena Milvidaite; Raimondas Kubilius; Jolanta Stasionyte
Journal:  Int J Biometeorol       Date:  2013-09-10       Impact factor: 3.787

Review 2.  Melatonin, mitochondria, and the metabolic syndrome.

Authors:  Daniel P Cardinali; Daniel E Vigo
Journal:  Cell Mol Life Sci       Date:  2017-08-17       Impact factor: 9.261

3.  Myocardial ischemia-reperfusion injury: Possible role of melatonin.

Authors:  Alberto Dominguez-Rodriguez; Pedro Abreu-Gonzalez
Journal:  World J Cardiol       Date:  2010-08-26

4.  MT2 receptors mediate the inhibitory effects of melatonin on nitric oxide-induced relaxation of porcine isolated coronary arteries.

Authors:  Radhika R Tunstall; Praveen Shukla; Anna Grazul-Bilska; Chengwen Sun; Stephen T O'Rourke
Journal:  J Pharmacol Exp Ther       Date:  2010-10-19       Impact factor: 4.030

Review 5.  Melatonin and the Brain-Heart Crosstalk in Neurocritically Ill Patients-From Molecular Action to Clinical Practice.

Authors:  Artur Bekała; Włodzimierz Płotek; Dorota Siwicka-Gieroba; Joanna Sołek-Pastuszka; Romuald Bohatyrewicz; Jowita Biernawska; Katarzyna Kotfis; Magdalena Bielacz; Andrzej Jaroszyński; Wojciech Dabrowski
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

6.  Age and Chronodisruption in Mouse Heart: Effect of the NLRP3 Inflammasome and Melatonin Therapy.

Authors:  Marisol Fernández-Ortiz; Ramy K A Sayed; Yolanda Román-Montoya; María Ángeles Rol de Lama; José Fernández-Martínez; Yolanda Ramírez-Casas; Javier Florido-Ruiz; Iryna Rusanova; Germaine Escames; Darío Acuña-Castroviejo
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

Review 7.  Melatonin as a protective agent in cardiac ischemia-reperfusion injury: Vision/Illusion?

Authors:  Puneet Kaur Randhawa; Manish Kumar Gupta
Journal:  Eur J Pharmacol       Date:  2020-08-26       Impact factor: 4.432

Review 8.  Roles of melatonin and its receptors in cardiac ischemia-reperfusion injury.

Authors:  Kodchanan Singhanat; Nattayaporn Apaijai; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Cell Mol Life Sci       Date:  2018-08-13       Impact factor: 9.261

9.  Molecular basis for defining the pineal gland and pinealocytes as targets for tumor necrosis factor.

Authors:  Claudia Emanuele Carvalho-Sousa; Sanseray da Silveira Cruz-Machado; Eduardo Koji Tamura; Pedro A C M Fernandes; Luciana Pinato; Sandra M Muxel; Erika Cecon; Regina P Markus
Journal:  Front Endocrinol (Lausanne)       Date:  2011-05-13       Impact factor: 5.555

10.  Effect of Melatonin on Cardiac Injury after Primary Percutaneous Coronary Intervention: a Randomized Controlled Trial.

Authors:  Padideh Ghaeli; Shaghayegh Vejdani; Atefeh Ariamanesh; Azita Hajhossein Talasaz
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.